Biotech Recovery Rally: Steady as She Goes-Biogen Rallies on Earnings…Update-1
Expect Modest Rally in Biotechs Through Q1 Earnings As of mid-day trading 1P EDT with flat NASDAQ Update at close: biotechs held onto gains despite a mild sell-off for the Dow and S&P with NASDAQ flat. Biogen (BIIB) gained a tad more up 5.16%. From here we'd like to see more rotation into...
Rayno Biopharmaceuticals 2016 Update: 4/14 All In the Green!
Rayno Biopharmaceutical Picks For 2016 Focus is larger cap stocks that pay dividends with one speculative pick (BLUE). XBI is a potential trade for momentum but the IBB can be used for larger cap rebalancing. New picks will be added should technicals in the sector hold. Large cap update after...
Biotech Rally Fizzles: Needs Help from M&A
Biotech Rally Loses Momentum But Still Up for the Week IBB up 3.37 % , XBI up 5.04% , XLV up 0.77% this week. Investors took profits today despite all of the media focus and renewed excitement for the long term potential of new blockbuster drugs. The rally began Wednesday with the news that the...
Healthcare Stocks Lead on a Lackluster Day…Update-1… Biotech Rally Continues
Update 4/6/16 Biotech Rally Picks Up Momentum Today IBB up 4.5%,XBI up 5% Speculative stocks lead the way: BLUE up 10%, VRX up 16.6% --------Risk on mode continues--------- Healthcare Sector Leads the Market Lagging healthcare and biotech stocks found buyers today.The healthcare SPDR ETF (XLV)...
Rayno Biopharmaceuticals: New Buy Idea- Roche plc (RHBBY)
Roche/Genentech Has a Strong Pipeline in Diagnostics and Therapeutics to Drive Moderate Growth in 2016 New Stock Pick: Roche Holding (OTCQX:RHHBY) $30.36 Over the past 3 months we recommended several new buys for the Rayno Biopharma Portfolio emphasizing moderate growth, relative safety and...